Schlumberger (SLB) financials
Schlumberger revenue and earnings by year
Schlumberger's revenue was $35.7 billion in the fiscal year to December 31, 2025, down 1.6% from the year before. Net income was $3.37 billion, 9.4% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 2.8% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 35.7 | 36.3 | 33.1 | 28.1 | 22.9 | 23.6 | 32.9 | 32.8 | 30.4 | 27.8 |
| Revenue growth | -1.6% | 9.5% | 18.0% | 22.5% | -2.8% | -28.3% | 0.3% | 7.8% | 9.5% | — |
| Gross profit | 6.5 | 7.5 | 6.6 | 5.2 | 3.7 | 2.6 | 4.2 | 4.3 | 3.9 | 3.4 |
| Gross margin | 18.2% | 20.6% | 19.8% | 18.4% | 16.0% | 11.0% | 12.8% | 13.2% | 12.8% | 12.2% |
| Operating income | 4.4 | 5.8 | 5.4 | 4.2 | 2.8 | -11.0 | -10.1 | 2.8 | -0.8 | -1.5 |
| Operating margin | 12.2% | 16.0% | 16.4% | 14.8% | 12.1% | -46.6% | -30.8% | 8.6% | -2.8% | -5.5% |
| Net income | 3.4 | 4.5 | 4.2 | 3.4 | 1.9 | -10.5 | -10.1 | 2.1 | -1.5 | -1.7 |
| Net margin | 9.4% | 12.3% | 12.7% | 12.2% | 8.2% | -44.6% | -30.8% | 6.5% | -4.9% | -6.1% |
| Diluted EPS | $2.35 | $3.11 | $2.91 | $2.39 | $1.32 | -$7.57 | -$7.32 | $1.53 | -$1.08 | -$1.24 |
| Free cash flow | 4.1 | 4.0 | 4.0 | 1.4 | 3.0 | 1.4 | 2.7 | 2.5 | 1.7 | 2.5 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open SLB in Markets.
See also: SLB valuation and P/E history · SLB returns
No forecast, no recommendation. This page describes Schlumberger from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.